NCT05359796Recruiting
Clinical Characteristics of People With Long-term Type 1 Diabetes
Clinical Characteristics of People With Long-term Type 1 Diabetes: a Cohort Study
Source: ClinicalTrials.gov · Last updated 4 May 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Type 1 diabetes (T1D) is characterized by absolute insulin deficiency. Although the discovery and application of exogenous insulin has prolonged the lifespan of T1D patients, the chronic diabetic complications caused by long-term poor glycemic control will still reduce patients' quality of life and the overall life expectancy. According to the studies focused on long-term T1D, part of the patients with long disease duration showed resistance to microvascular complications, and several protective factors have been identified. The prevalence of T1D in China is extremely low compared to that in the western world, and little is known about the characteristics of patients with long-term T1D in China. Therefore, this study is designed to collect variable clinical and laboratory features of patients with long-term T1D, explore the risk and protective factors for the development of microvascular complications, and provide reference for the prediction and prevention of these complications.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 24 Apr 2022
- Start date
- 1 May 2022
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Second Xiangya Hospital of Central South University
- Diseases
- Type 1 diabetes
- NCT number
- NCT05359796
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 May 2022 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with type 2 diabetes, gestational diabetes, or specific types of diabetes
- patients with mental disability or have any other condition or disease that may hamper compliance with the protocol
Who the study is looking for
- Individuals diagnosed with type 1 diabetes(T1D) according to the 1999 World Health Organization report
- Insulin dependence from disease onset
- with T1D duration of ≥10 years
- able to understand the procedures and methods of this study, voluntarily participate in the study, and agree to sign the informed consent form
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
Related publications
- Integrative oral and gut microbiome profiling highlights microbial correlates of complications in type 1 diabetes: a cross-sectional analysis.Cardiovasc Diabetol · 2025 · PMID 41444596
This page is information, not medical advice. Discuss any trial with your doctor.